Site Payments Still a Pressing Issue for Clinical Trials, Industry Agrees
Sponsors, CROs and sites themselves agree that delayed site payments are still a significant issue in clinical research — so significant that they identified it as the most important activity to address in a recent survey.
According to Greenphire’s 2022 Market Trends Survey, which involved 510 site personnel and 274 sponsor/CRO reps from around the world, the majority of respondents believe it’s critical for sponsors and CROs to streamline site payments and invoicing in order to improve their working relationships with sites.
The findings were overwhelming: 82 percent of site representatives said that they are negatively affected by delays in site payments from sponsors, while 85 percent said they would rather work with sponsors/CROs that invest in technologies that address site payment hurdles, such as systems that help with invoice creation, distribution and reconciliation.
Access the full survey findings here: https://bit.ly/3dB6zsC.